Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Price | 1d % | 1w % | 1m % | 3m % | 6m % | 1y % | 3y % | 5y % | 10y % | 52-week High | 52-week Low | % off 52-week High | % off 52-week Low | Beta | Volume | Vol 1d % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SLNO | SOLENO THERAPEUTICS INC | $39.49 | 6.76% | 23.95% | 1.10% | -16.28% | -31.89% | -46.40% | 1,695.00% | 110.61% | -58.86% | $90.32 | $29.43 | 56.28% | 34.18% | 0.42 | 3,575,000 | 22.89% |
| ALNY | ALNYLAM PHARMACEUTICALS INC | $318.85 | -3.01% | -2.84% | -1.91% | -20.32% | -30.83% | 19.50% | 58.87% | 123.52% | 372.09% | $495.55 | $205.87 | 35.66% | 54.88% | 0.89 | 872,000 | 34.78% |
| ADMA | ADMA BIOLOGICS INC | $9.19 | 0.88% | 10.86% | -44.57% | -48.60% | -36.75% | -54.57% | 176.81% | 402.19% | 6.86% | $25.67 | $7.21 | 64.20% | 27.46% | 1.22 | 6,126,000 | -21.20% |
| ZVRA | ZEVRA THERAPEUTICS INC | $9.40 | -0.11% | 0.00% | 3.41% | 12.71% | 0.97% | 22.72% | 69.37% | -4.95% | -96.34% | $13.16 | $6.19 | 28.57% | 51.86% | 0.88 | 587,000 | 10.96% |
| CORT | CORCEPT THERAPEUTICS INC | $42.49 | 1.21% | 10.28% | 18.13% | 11.23% | -50.29% | -49.30% | 88.76% | 76.01% | 807.91% | $91.00 | $28.66 | 53.31% | 48.26% | 0.97 | 1,498,000 | -22.94% |
| ABEO | ABEONA THERAPEUTICS INC | $4.82 | 5.24% | 11.32% | -4.74% | -9.23% | -9.40% | 2.99% | 70.32% | -89.58% | -93.59% | $7.54 | $3.93 | 36.07% | 22.55% | 0.88 | 767,000 | -8.80% |
| HALO | HALOZYME THERAPEUTICS INC | $64.49 | -1.39% | 1.90% | -7.67% | -8.28% | -10.04% | 2.33% | 66.47% | 50.22% | 536.62% | $82.22 | $47.50 | 21.56% | 35.77% | 0.80 | 1,523,000 | 12.73% |
| KRYS | KRYSTAL BIOTECH INC | $260.95 | 0.79% | 3.80% | 0.83% | 5.69% | 43.62% | 44.17% | 224.77% | 231.37% | N/A | $298.30 | $122.80 | 12.52% | 112.50% | 1.33 | 204,000 | -41.21% |
| RPRX | ROYALTY PHARMA PLC | $48.57 | 0.16% | 3.47% | 2.32% | 24.99% | 33.10% | 55.27% | 35.37% | 13.75% | N/A | $49.06 | $29.66 | 1.00% | 63.76% | 0.47 | 2,730,000 | -24.04% |
| VCEL | VERICEL CORP | $34.14 | 4.85% | 10.77% | -3.45% | -4.13% | 8.31% | -22.95% | 16.00% | -37.09% | 817.74% | $45.97 | $28.95 | 25.73% | 17.93% | 1.49 | 1,686,000 | 159.78% |
| NAGE | NIAGEN BIOSCIENCE INC | $4.38 | -3.10% | -2.01% | -12.22% | -29.92% | -40.65% | -38.14% | 190.07% | -59.89% | 1.39% | $14.69 | $4.16 | 70.18% | 5.29% | 1.50 | 753,000 | 6.06% |
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $27.74 | -0.79% | 1.09% | -4.01% | -25.79% | 3.66% | -14.72% | -16.42% | -16.95% | N/A | $40.87 | $25.52 | 32.13% | 8.70% | 0.84 | 524,000 | -15.62% |
| TECH | BIO-TECHNE CORP | $53.13 | -0.65% | 0.82% | -8.11% | -10.93% | -14.43% | -8.99% | -27.97% | -46.44% | 124.53% | $72.16 | $46.01 | 26.37% | 15.47% | 1.16 | 1,802,000 | -25.72% |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $55.50 | -3.04% | -0.09% | -7.10% | -6.64% | -0.13% | -18.76% | -42.55% | -29.14% | -34.30% | $66.28 | $50.76 | 16.26% | 9.34% | 0.72 | 2,316,000 | 10.34% |
| APLS | APELLIS PHARMACEUTICALS INC | $40.41 | 0.05% | 129.08% | 95.22% | 56.26% | 74.86% | 75.70% | -47.30% | -5.89% | N/A | $40.48 | $16.10 | 0.17% | 150.99% | 1.25 | 10,333,000 | -65.58% |
| MNKD | MANNKIND CORP | $2.50 | -1.57% | 8.70% | -17.63% | -55.36% | -54.46% | -50.20% | -39.47% | -40.19% | -70.41% | $6.51 | $2.23 | 61.60% | 12.11% | 1.10 | 3,758,000 | 9.21% |
| EXEL | EXELIXIS INC | $43.88 | -0.36% | 3.59% | 6.95% | 0.69% | 6.12% | 18.47% | 125.26% | 86.88% | 930.05% | $49.62 | $32.38 | 11.57% | 35.52% | 0.60 | 1,665,000 | -9.46% |
| CPRX | CATALYST PHARMACEUTICALS INC | $24.69 | -0.52% | 1.81% | 3.39% | 6.65% | 18.47% | 0.94% | 45.75% | 421.99% | 1,957.50% | $26.58 | $19.05 | 7.11% | 29.61% | 1.02 | 616,000 | -57.40% |
| REGN | REGENERON PHARMACEUTICALS INC | $761.85 | -1.98% | 0.68% | -3.66% | -1.86% | 26.98% | 21.78% | -7.79% | 57.23% | 87.97% | $821.11 | $476.49 | 7.22% | 59.89% | 0.60 | 1,001,000 | 59.65% |
| VCYT | VERACYTE INC | $32.25 | -0.46% | -1.68% | -10.44% | -23.92% | -9.49% | 7.04% | 45.47% | -43.04% | 516.63% | $50.71 | $22.61 | 36.40% | 42.64% | 1.90 | 703,000 | 14.12% |
| LGND | LIGAND PHARMACEUTICALS INC | $199.59 | -0.02% | -2.02% | -1.46% | 4.99% | 10.81% | 83.56% | 178.83% | 30.01% | 78.76% | $227.92 | $93.58 | 12.43% | 113.28% | 1.14 | 222,000 | 1.37% |
| VRTX | VERTEX PHARMACEUTICALS INC | $438.71 | -1.91% | -3.31% | -9.74% | -2.97% | 7.30% | -9.26% | 38.69% | 103.75% | 429.40% | $510.77 | $362.50 | 14.11% | 21.02% | 0.57 | 1,245,000 | 5.60% |
| UTHR | UNITED THERAPEUTICS CORP | $564.81 | -0.96% | 6.06% | 9.92% | 13.71% | 27.37% | 80.88% | 150.67% | 193.03% | 397.54% | $607.89 | $266.98 | 7.09% | 111.56% | 0.42 | 831,000 | 17.87% |
| XOMA | XOMA ROYALTY CORP | $32.98 | -0.30% | 8.02% | 25.83% | 17.83% | -16.59% | 66.73% | 56.67% | -17.34% | 99.47% | $39.92 | $18.35 | 17.38% | 79.71% | 0.81 | 93,500 | -45.00% |
| INCY | INCYTE CORP | $95.93 | 1.73% | 3.98% | -4.11% | -5.41% | 11.18% | 53.91% | 32.03% | 15.23% | 30.53% | $112.29 | $53.56 | 14.57% | 79.11% | 0.55 | 1,160,000 | -19.16% |
| CRMD | CORMEDIX INC | $7.05 | 0.43% | 5.22% | -2.22% | -42.02% | -36.20% | 11.90% | 62.82% | -28.06% | -56.48% | $17.43 | $5.60 | 59.55% | 25.89% | 1.10 | 1,671,000 | 42.94% |
| MDXG | MIMEDX GROUP INC | $3.92 | -0.76% | -0.51% | -19.67% | -39.51% | -41.58% | -49.02% | 17.37% | -65.43% | -56.10% | $7.99 | $3.77 | 50.94% | 3.98% | 1.29 | 1,679,000 | 17.09% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.